Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV vs. SC filgrastim for neutropenia in haemato-oncological patients
NCT01222819Phase 4Terminated
- Sponsor
- Rabin Medical Center
- Start
- Jan 2011
- Primary completion
- Dec 2012
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of filgrastim in neutropenia, sponsored by Rabin Medical Center. Started Jan 2011; status: terminated.
02
Drugs
filgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT01222819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01222819.